Holen Sie sich die Stockscreener-App
3.90
0.00%
0.00
Handel nachbörslich:
3.95
0.05
+1.28%
Schlusskurs vom Vortag:
$3.90
Offen:
$3.95
24-Stunden-Volumen:
1.91M
Relative Volume:
0.46
Marktkapitalisierung:
$1.42B
Einnahmen:
$2.59M
Nettoeinkommen (Verlust:
$-137.89M
KGV:
-4.8148
EPS:
-0.81
Netto-Cashflow:
$-69.76M
1W Leistung:
+1.30%
1M Leistung:
-4.18%
6M Leistung:
+9.24%
1J Leistung:
+168.97%
1-Tages-Spanne:
$3.89
$3.97
1-Wochen-Bereich:
$3.77
$4.1699
52-Wochen-Spanne:
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
49 89 2153 9035
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Vergleichen Sie ATAI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.90 | 1.42B | 2.59M | -137.89M | -69.76M | -0.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
AtaiBeckley Inc. (ATAI) Stock Analysis: A Biotech Gem With Over 200% Upside Potential - directorstalkinterviews.com
Psychedelic: Analyst initiates Atai Beckley with Buy rating - TipRanks
Assessing AtaiBeckley (ATAI) Valuation After Recent Share Price Pullback - simplywall.st
Small cap wrap: American Resources, C3 Metals, TNR Gold, AtaiBeckley... - Proactive Investors
Assessing AtaiBeckley (ATAI) Valuation After Trial Success Index Addition Capital Raise And US Move - Yahoo Finance
AtaiBeckley seen as key beneficiary of Spravato’s strong growth: Jefferies - Proactive financial news
AtaiBeckley Weighs Late Stage Options After Milestones And US$300m Raise - simplywall.st
The Bull Case For AtaiBeckley (ATAI) Could Change Following Promising BPL-003 Phase 2b Depression Data - Yahoo Finance
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026 - Finviz
Atai Beckley N.V. (ATAI) Achieves Significant Milestone on Pipeline Development and Corporate Foundation - Finviz
Assessing AtaiBeckley (ATAI) After A 149% Year Following Biotech Sector Sentiment Shift - simplywall.st
Is AtaiBeckley (ATAI) Turning Psychedelic Trial Momentum Into a Durable Mental Health Moat? - simplywall.st
Interesting ATAI Call Options For March 20th - Nasdaq
Atai Beckley announces presentations at ACNP - TipRanks
Small cap wrap: Nextech3D.ai, Aftermath Silver, Tiziana Life Sciences, AtaiBeckley… - Proactive financial news
AtaiBeckley shares clinical and preclinical data at ACNP Annual Meeting - Proactive financial news
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation - Investing News Network
AtaiBeckley Inc. Showcases Breakthrough Findings on BPL-003 for Treatment-Resistant Depression at ACNP Annual Meeting - Quiver Quantitative
Single-dose nasal spray shows rapid effect in hard-to-treat depression - Stock Titan
A Look At AtaiBeckley (ATAI) Valuation After Phase 2b Progress And Delaware Redomiciliation - simplywall.st
Atai Beckley N.V. (ATAI) is a Buy on Mental Therapeutics Opportunities - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
AtaiBeckley Completes Redomiciliation to the United States - Investing News Network
New Strong Sell Stocks for Jan. 13 - The Globe and Mail
atai Life Sciences stock rating reiterated by Cantor Fitzgerald - Investing.com
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio - Investing News Network
AtaiBeckley Added to the Nasdaq Biotechnology Index - Investing News Network
Is It Too Late To Reassess AtaiBeckley (ATAI) After A 150% One Year Rally? - simplywall.st
Is It Too Late To Consider AtaiBeckley (ATAI) After A 145% One-Year Surge? - Yahoo Finance
Atai Beckley CEO says entering 2026 with ‘meaningful momentum’ - The Globe and Mail
AtaiBeckley outlines 2026 mental health treatment pipeline milestones By Investing.com - Investing.com Nigeria
Optimism flows from pot to psychedelics: Atai Beckley, Supernus stocks rise after analyst flags positive tailwinds from Trump’s marijuana order - MSN
Small cap wrap: AtaiBeckley, MustGrow Biologics, Silver Range Resources... - Proactive Investors
Needham Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
AtaiBeckley outlines 2026 mental health treatment pipeline milestones - Investing.com
AtaiBeckley Inc Provides 2026 Outlook and Clinical Updates Ahead of J.P. Morgan Healthcare Conference - Quiver Quantitative
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference - The Manila Times
AtaiBeckley issues 2026 outlook, flags multiple clinical milestones - Proactive financial news
Redomiciliation And Deregistration Move Could Be A Game Changer For AtaiBeckley (ATAI) - simplywall.st
Free float of AtaiBeckley Inc. – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Earnings and Revenue – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Income Statement – BMV:ATAI - TradingView — Track All Markets
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView — Track All Markets
AtaiBeckley Inc. Cash Flow – FWB:B72 - TradingView — Track All Markets
Diluted net income available to common stockholders of AtaiBeckley Inc. – GETTEX:B72 - TradingView — Track All Markets
AtaiBeckley Inc. Financial Disclosures & Filings - TradingView — Track All Markets
AtaiBeckley Inc. Statistics – XETR:B72 - TradingView — Track All Markets
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):